Vaxxinity (VAXX)
(Delayed Data from OTC)
$0.00 USD
0.00 (900.00%)
Updated Aug 30, 2024 09:31 AM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Vaxxinity, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 31 | 88 | 145 | 31 | 0 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 3 | 6 | 9 | 5 | 1 |
Total Current Assets | 33 | 94 | 154 | 36 | 1 |
Net Property & Equipment | 11 | 13 | 12 | 12 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 2 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 44 | 106 | 167 | 50 | 2 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 2 | 2 | 0 | 28 | 13 |
Accounts Payable | 2 | 5 | 3 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 11 | 5 | 1 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 11 | 13 | 19 | 8 | 5 |
Total Current Liabilities | 18 | 31 | 27 | 37 | 20 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 1 |
Long-Term Debt | 13 | 13 | 10 | 11 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 27 | 2 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 62 | 27 |
Total Liabilities | 31 | 44 | 38 | 138 | 50 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 375 | 367 | 358 | 5 | 4 |
Retained Earnings | -362 | -305 | -229 | -92 | -52 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 13 | 62 | 129 | -87 | -49 |
Total Liabilities & Shareholder's Equity | 44 | 106 | 167 | 50 | 2 |
Total Common Equity | 13 | 62 | 129 | -87 | -49 |
Shares Outstanding | 126.70 | 126.00 | 125.30 | NA | NA |
Book Value Per Share | 0.11 | 0.49 | 1.03 | 0.00 | 0.00 |
Fiscal Year End for Vaxxinity, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | 31 | 43 | 56 |
Receivables | NA | NA | 0 | 0 | 0 |
Notes Receivable | NA | NA | 0 | 0 | 0 |
Inventories | NA | NA | 0 | 0 | 0 |
Other Current Assets | NA | NA | 3 | 4 | 4 |
Total Current Assets | NA | NA | 33 | 46 | 60 |
Net Property & Equipment | NA | NA | 11 | 11 | 12 |
Investments & Advances | NA | NA | 0 | 0 | 0 |
Other Non-Current Assets | NA | NA | 0 | 0 | 0 |
Deferred Charges | NA | NA | 0 | 0 | 0 |
Intangibles | NA | NA | 0 | 0 | 0 |
Deposits & Other Assets | NA | NA | 0 | 0 | 0 |
Total Assets | NA | NA | 44 | 57 | 71 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 2 | 1 | 1 |
Accounts Payable | NA | NA | 2 | 3 | 2 |
Current Portion Long-Term Debt | NA | NA | 0 | 0 | 0 |
Current Portion Capital Leases | NA | NA | 0 | 0 | 0 |
Accrued Expenses | NA | NA | 3 | 5 | 8 |
Income Taxes Payable | NA | NA | 0 | 0 | 0 |
Other Current Liabilities | NA | NA | 11 | 13 | 13 |
Total Current Liabilities | NA | NA | 18 | 22 | 24 |
Mortgages | NA | NA | 0 | 0 | 0 |
Deferred Taxes/Income | NA | NA | 0 | 0 | 0 |
Convertible Debt | NA | NA | 0 | 0 | 0 |
Long-Term Debt | NA | NA | 13 | 12 | 12 |
Non-Current Capital Leases | NA | NA | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | NA | 0 | 0 | 0 |
Total Liabilities | NA | NA | 31 | 34 | 36 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | 0 | 0 |
Common Stock (Par) | NA | NA | 0 | 0 | 0 |
Capital Surplus | NA | NA | 375 | 374 | 372 |
Retained Earnings | NA | NA | -362 | -350 | -337 |
Other Equity | NA | NA | 0 | 0 | 0 |
Treasury Stock | NA | NA | 0 | 0 | 0 |
Total Shareholder's Equity | NA | NA | 13 | 24 | 35 |
Total Liabilities & Shareholder's Equity | NA | NA | 44 | 57 | 71 |
Total Common Equity | 0 | 0 | 13 | 24 | 35 |
Shares Outstanding | 126.70 | 126.70 | 126.70 | 126.70 | 126.70 |
Book Value Per Share | 0.00 | 0.00 | 0.11 | 0.19 | 0.28 |